scholarly journals Subpleural curvilinear shadow of eosinophilic pneumonia simulating pneumothorax

2021 ◽  
Vol 69 (4) ◽  
pp. 569-571
Author(s):  
So Hattori ◽  
Yuika Sasatani ◽  
Hiroaki Satoh
Keyword(s):  
Eosinophilic Pneumonia

Chronic Eosinophilic Pneumonia: A Case Report

1995 ◽  
Vol 32 (5) ◽  
pp. 733
Author(s):  
Hae Jeong Jeon ◽  
Jeong Hee Park ◽  
Jong Nam Lim ◽  
Tae Haeng Heo ◽  
Hyun Jun Shin
Keyword(s):  
Case Report ◽  
Eosinophilic Pneumonia ◽  
Chronic Eosinophilic Pneumonia

Mesalazine-induced acute eosinophilic pneumonia

2019 ◽  
Vol 40 (1) ◽  
pp. 42-46 ◽  
Author(s):  
Y Charaf ◽  
JP Potier ◽  
T Njambou ◽  
L Hubin ◽  
V Vandermoten ◽  
...  
Keyword(s):  
Eosinophilic Pneumonia ◽  
Acute Eosinophilic Pneumonia

Daptomycin associated eosinophilic pneumonia

2021 ◽  
Vol 156 (3) ◽  
pp. 148-149
Author(s):  
Raquel Fernández-González ◽  
María Dolores Díaz López ◽  
Ana María Lorenzo Vizcaya ◽  
Amara González Noya
Keyword(s):  
Eosinophilic Pneumonia

scholarly journals Risk Factors of Daptomycin-Induced Eosinophilic Pneumonia in a Population with Osteoarticular Infection

Antibiotics ◽  
2021 ◽  
Vol 10 (4) ◽  
pp. 446
Author(s):  
Laura Soldevila-Boixader ◽  
Bernat Villanueva ◽  
Marta Ulldemolins ◽  
Eva Benavent ◽  
Ariadna Padulles ◽  
...  
Keyword(s):  
Risk Factors ◽  
Adverse Effect ◽  
Cohort Study ◽  
Retrospective Cohort Study ◽  
Older Patients ◽  
Retrospective Cohort ◽  
Joint Infection ◽  
Eosinophilic Pneumonia ◽  
Severe Adverse Effect ◽  
Osteoarticular Infection

Background: Daptomycin-induced eosinophilic pneumonia (DEP) is a rare but severe adverse effect and the risk factors are unknown. The aim of this study was to determine risk factors for DEP. Methods: A retrospective cohort study was performed at the Bone and Joint Infection Unit of the Hospital Universitari Bellvitge (January 2014–December 2018). To identify risk factors for DEP, cases were divided into two groups: those who developed DEP and those without DEP. Results: Among the whole cohort (n = 229) we identified 11 DEP cases (4.8%) and this percentage almost doubled in the subgroup of patients ≥70 years (8.1%). The risk factors for DEP were age ≥70 years (HR 10.19, 95%CI 1.28–80.93), therapy >14 days (7.71, 1.98–30.09) and total cumulative dose of daptomycin ≥10 g (5.30, 1.14–24.66). Conclusions: Clinicians should monitor cumulative daptomycin dosage to minimize DEP risk, and be cautious particularly in older patients when the total dose of daptomycin exceeds 10 g.

Chronic Eosinophilic Pneumonia: Treatment with Inhaled Corticosteroids

Respiration ◽  
2003 ◽  
Vol 70 (4) ◽  
pp. 362-366 ◽  
Author(s):  
Masayoshi Minakuchi ◽  
Akio Niimi ◽  
Hisako Matsumoto ◽  
Ryoichi Amitani ◽  
Michiaki Mishima
Keyword(s):  
Inhaled Corticosteroids ◽  
Eosinophilic Pneumonia ◽  
Chronic Eosinophilic Pneumonia
Sign in / Sign up

Export Citation Format

Share Document